Galaxy Surfactants Ltd
Galaxy Surfactants Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Volume growth guidance maintained at 6% to 8% annually, though subject to market uncertainties (Page 14). - Expectation of double-digit volume growth in specialty surfactants, especially with the resolution of U.S. Galaxy Surfactants expects the EPS/growth to normalize post-tariff resolution in the U.S.
From Galaxy Surfactants Ltd's Q3 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Volume growth guidance maintained at 6% to 8% annually, though subject to market uncertainties (Page 14).
- Expectation of double-digit volume growth in specialty surfactants, especially with the resolution of U.S. tariffs and rebounding demand (Pages 9, 14).
- Growth recovery anticipated in AMET region from Q4 onwards but peak volumes there unlikely to return within 1-1.5 years due to competition and market changes (Page 7).
- India market expected to return to double-digit growth following reformulation approvals and GST rationalization, supporting volume momentum (Pages 7-8).
2 more points from Galaxy Surfactants Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Galaxy Surfactants Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company has engaged in an EPC (Engineering, Procurement, and Construction) business with a single customer, expected to complete by Q4 of next financial year, with revenue and earnings recognized in small pockets rather than lump sums.
- This EPC engagement is part of a strategic intent to backward integrate and gain access to volumes in the U.S., their biggest market for Home and Personal Care, especially for Performance Surfactants.
- Although EPC revenues are currently not significant in EBITDA terms, the relationship with the customer and strategic position are viewed as beneficial for future volume growth.
2 more points from Galaxy Surfactants Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Galaxy Surfactants Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Galaxy Surfactants Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Galaxy Surfactants Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.3K Cr, net profit ₹62 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Galaxy Surfactants Ltd's management said in earlier quarters
- Q2 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Neochem Bio Solutions Ltd (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chemicals Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- Jubilant Agri & Consumer Products Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations: INR 4,510 million, up 13% YoY from INR 3,975 million in Q3 FY25 (Page 20). Key investor presentation takeaways from Jubilant Ag
- Chemfab Alka. (Q3 FY26)
Revenue from Operation: ₹62.17 crore, down 21.51% YoY (₹79.21 crore in Q3FY25) . Key investor presentation takeaways from Chemfab Alka.'s Q3 FY26 investor prese
Arthneeti Pro · Annual
Galaxy Surfactants Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Galaxy Surfactants Ltd Q3 FY26 results?
Volume growth guidance maintained at 6% to 8% annually, though subject to market uncertainties (Page 14). - Expectation of double-digit volume growth in specialty surfactants, especially with the resolution of U.S. Galaxy Surfactants expects the EPS/growth to normalize post-tariff resolution in the U.S.
What is Galaxy Surfactants Ltd share price analysis?
Galaxy Surfactants Ltd currently shows a neutral. The stock trades at a P/E of 24.4 with a market cap of ₹8,872 Cr. Investors should review the full earnings analysis for detailed insights.
Is Galaxy Surfactants Ltd planning capital expenditure?
The company has engaged in an EPC (Engineering, Procurement, and Construction) business with a single customer, expected to complete by Q4 of next financial year, with revenue and earnings recognized in small pockets rather than lump sums. - This EPC engagement is part of a strategic intent to backward integrate and gain access to volumes in the U.S., their biggest market for Home and Personal Care, especially for Performance Surfactants. - Although EPC revenues are currently not significant in EBITDA terms, the relationship with the customer and strategic position are viewed as beneficial for future volume growth. - No major or bulk capital expenditure is expected in any single quarter; investment returns will be gradual and linked to project completion percentages.
Keep Galaxy Surfactants Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.